Catalog No.
KDV02804
Detection method
Colorimetric
Sample type
Plasma, Serum
Assay type
Quantitative
Range
78.125 - 5,000 ng/mL
Sensitivity
33.12 ng/mL
Precision
CV<20%
Recovery
80-120%
Shipping
2-8 ℃
Stability and Storage
The stability of ELISA kit is determined by the loss rate of activity. The loss rate of this kit is less than 10% prior to the expiration date under appropriate storage condition.
Alternative Names
MK 1654, MK-1654, MK1654, RB1, CAS: 2429913-18-6
Supporting Pediatric RSV Clinical Trials Through Close Epidemiological Surveillance During the SARS-CoV-2 Pandemic., PMID:40312764
Human iPS cell-derived respiratory organoids as a model for respiratory syncytial virus infection., PMID:40262853
Efficacy of monoclonal antibodies and maternal vaccination for prophylaxis of respiratory syncytial virus disease., PMID:40240559
Anti-Idiotypic Antibody as a Booster Vaccine Against Respiratory Syncytial Virus., PMID:39852814
The recent landscape of RSV vaccine research., PMID:39802673
A Phase 1b/2a Trial of a Half-life Extended Respiratory Syncytial Virus Neutralizing Antibody, Clesrovimab, in Healthy Preterm and Full-term Infants., PMID:39601265
Development of High-Titer Antidrug Antibodies in a Phase 1b/2a Infant Clesrovimab Trial Are Associated With RSV Exposure Beyond Day 150., PMID:39590882
Mind the (preterm) gap: inequality in the UK's current RSV immunisation approach will leave many preterm babies unprotected against RSV this winter., PMID:39379140
Systematic Review of the Efficacy and Safety of RSV-Specific Monoclonal Antibodies and Antivirals in Development., PMID:39209729
Genomic evolution of human respiratory syncytial virus during a decade (2013-2023): bridging the path to monoclonal antibody surveillance., PMID:38588960
[Prevention of respiratory syncytial virus infection in infants. What has been done and where are we today?]., PMID:38329302
Quantification of clesrovimab, an investigational, half-life extended, anti-respiratory syncytial virus protein F human monoclonal antibody in the nasal epithelial lining fluid of healthy adults., PMID:37976891
Development of mRNA vaccines against respiratory syncytial virus (RSV)., PMID:36280532